A detailed history of Americana Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Americana Partners, LLC holds 51,931 shares of NVO stock, worth $4.54 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
51,931
Previous 49,368 5.19%
Holding current value
$4.54 Million
Previous $7.05 Million 12.25%
% of portfolio
0.45%
Previous 0.6%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$119.07 - $145.42 $305,176 - $372,711
2,563 Added 5.19%
51,931 $6.18 Million
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $203,330 - $243,429
1,657 Added 3.47%
49,368 $7.05 Million
Q1 2024

May 07, 2024

BUY
$102.11 - $135.92 $138,869 - $184,851
1,360 Added 2.93%
47,711 $6.13 Million
Q4 2023

Jan 25, 2024

SELL
$87.78 - $105.45 $427,576 - $513,646
-4,871 Reduced 9.51%
46,351 $4.8 Million
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $3.03 Million - $6.65 Million
33,330 Added 186.28%
51,222 $4.66 Million
Q2 2023

Jul 31, 2023

BUY
$155.98 - $172.65 $14,194 - $15,711
91 Added 0.51%
17,892 $2.9 Million
Q1 2023

May 08, 2023

SELL
$132.34 - $159.14 $132 - $159
-1 Reduced 0.01%
17,801 $2.83 Million
Q4 2022

Jan 30, 2023

SELL
$102.55 - $135.33 $15,279 - $20,164
-149 Reduced 0.83%
17,802 $2.41 Million
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $63,265 - $77,641
664 Added 3.84%
17,951 $1.79 Million
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $20,028 - $23,631
-194 Reduced 1.11%
17,287 $1.91 Million
Q1 2022

May 06, 2022

BUY
$93.1 - $112.54 $1.63 Million - $1.97 Million
17,481 New
17,481 $276,000
Q1 2020

May 12, 2020

SELL
$49.46 - $64.78 $36,056 - $47,224
-729 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$49.86 - $58.26 $36,347 - $42,471
729 New
729 $42,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Americana Partners, LLC Portfolio

Follow Americana Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Americana Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Americana Partners, LLC with notifications on news.